Clinical Trial Update: A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial of ITU512 in healthy participants and sickle cell disease patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• ITU512

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: RECRUITING